The levels of long-term blood sugar, HbA1c, can be used to accurately determine the risk of a person with type 1 diabetes developing eye- and kidney complications. A study from Linköping University, Sweden, has shown that ...
Sep 12, 2022
0
66
It's easy to be complacent about COVID-19. Most people experience only mild issues—fever and coughing, maybe congestion and shortness of breath.
Jan 18, 2024
0
41
Researchers show that use of senolytics can improve the reparative properties of human heart cells by eliminating senescent "zombie cells," known to be associated with cardiovascular disease and other age-related conditions
Apr 20, 2023
0
10
The key to curing male pattern baldness—a condition that affects up to 50% of men worldwide—could lie in a sugar that naturally occurs in the human body, according to scientists at the University of Sheffield.
Jul 22, 2024
0
34
When the human body sustains injury, cells spring into action. New blood vessels emerge through a process called angiogenesis, and cells migrate in a coordinated campaign of healing.
Jul 29, 2020
0
236
New research has laid the groundwork for a long-lasting eye drop to treat corneal neovascularisation (CoNV), a condition which affects more than a million people globally each year.
Jan 25, 2022
0
99
A new study led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center shows ixabepilone plus bevacizumab (IXA+BEV) is a well-tolerated, effective combination for treatment of platinum/taxane-resistant ...
Feb 14, 2022
0
19
We are as old as our arteries, the adage goes, so could reversing the aging of blood vessels hold the key to restoring youthful vitality?
Mar 22, 2018
0
148
Most living things need oxygen to grow and thrive. Even cancerous tumors. That's why tumors will readily sprout new blood vessels if their oxygen is starved, creating new lifelines for survival.
Dec 22, 2020
0
340
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov 20, 2020
0
3
